1
|
Seyfi S, Salarinejad S, Moghimi S, Toolabi M, Sadeghian N, Tüzün B, Firoozpour L, Ketabforoosh SHME, Taslimi P, Foroumadi A. Synthesis, biological activities, and molecular docking studies of triazolo[4,3-b]triazine derivatives as a novel class of α-glucosidase and α-amylase inhibitors. Arch Pharm (Weinheim) 2024; 357:e2300628. [PMID: 38501879 DOI: 10.1002/ardp.202300628] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/29/2023] [Revised: 02/12/2024] [Accepted: 02/13/2024] [Indexed: 03/20/2024]
Abstract
In diabetes mellitus, amylase and glucosidase enzymes are the primary triggers. The main function of these enzymes is to break macromolecules into simple sugar units, which directly affect blood sugar levels by increasing blood permeability. To overcome this metabolic effect, there is a need for a potent and effective inhibitor capable of suppressing the enzymatic conversion of sugar macromolecules into their smaller units. Herein, we reported the discovery of a series of substituted triazolo[4,3-b][1,2,4]triazine derivatives as α-glucosidase and α-amylase inhibitors. All target compounds demonstrated significant inhibitory activities against α-glucosidase and α-amylase enzymes compared with acarbose as the positive control. The most potent compound 10k, 2-[(6-phenyl-[1,2,4]triazolo[4,3-b][1,2,4]triazin-3-yl)thio]-N-[4-(trifluoromethyl)phenyl]acetamide, demonstrated IC50 values of 31.87 and 24.64 nM against α-glucosidase and α-amylase enzymes, respectively. To study their mechanism of action, kinetic studies were also done, which determined the mode of inhibition of both enzymes. Molecular docking was used to confirm the binding interactions of the most active compounds.
Collapse
Affiliation(s)
- Soheila Seyfi
- Drug Design and Development Research Center, The Institute of Pharmaceutical Sciences (TIPS), Tehran University of Medical Sciences, Tehran, Iran
| | - Somayeh Salarinejad
- Department of Medicinal Chemistry, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
| | - Setareh Moghimi
- Drug Design and Development Research Center, The Institute of Pharmaceutical Sciences (TIPS), Tehran University of Medical Sciences, Tehran, Iran
| | - Mahsa Toolabi
- Department of Medicinal Chemistry, School of Pharmacy, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
| | - Nastaran Sadeghian
- Department of Biotechnology, Faculty of Science, Bartin University, Bartin, Turkey
| | - Burak Tüzün
- Plant and Animal Production Department, Technical Sciences Vocational School of Sivas, Sivas Cumhuriyet University, Sivas, Turkey
| | - Loghman Firoozpour
- Drug Design and Development Research Center, The Institute of Pharmaceutical Sciences (TIPS), Tehran University of Medical Sciences, Tehran, Iran
- Department of Medicinal Chemistry, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
| | - Shima H M E Ketabforoosh
- Department of Medicinal Chemistry, School of Pharmacy, Alborz University of Medical Science, Karaj, Iran
| | - Parham Taslimi
- Department of Biotechnology, Faculty of Science, Bartin University, Bartin, Turkey
| | - Alireza Foroumadi
- Drug Design and Development Research Center, The Institute of Pharmaceutical Sciences (TIPS), Tehran University of Medical Sciences, Tehran, Iran
- Department of Medicinal Chemistry, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
| |
Collapse
|
2
|
Rusinov VL, Sapozhnikova IM, Spasov AA, Chupakhin ON. Fused azoloazines with antidiabetic activity. Russ Chem Bull 2022. [DOI: 10.1007/s11172-022-3687-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/01/2023]
|
3
|
Yakovlev DS, Vassiliev PM, Agatsarskaya YV, Brigadirova AA, Sultanova KT, Skripka MO, Spasov AA, Savateev KV, Rusinov VL, Maltsev DV. Searching for novel antagonists of adenosine A1 receptors among azolo[1,5-a]pyrimidine nitro derivatives. RESEARCH RESULTS IN PHARMACOLOGY 2022. [DOI: 10.3897/rrpharmacology.8.77854] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Introduction: Ligands of adenosine A1Rs are potential candidates for the development of drugs for the treatment of paroxysmal supraventricular tachycardia, angina pectoris, hypertriglyceridemia, type 2 diabetes mellitus, neuropathic pain, and heart failure. At the same time, there is a deficiency of drugs that can regulate the functions of A1 receptors. A number of A1-antagonists are at the various stages of clinical trials; other drugs are not very selective or are characterized by an insufficient breadth of their therapeutic action. Therefore, the search for new medicinal compounds for the prevention and treatment of A1-depended diseases among nitro derivatives of tetrazolo[1,5-a]pyrimidine and 1,2,4-triazolo[1,5-a]pyrimidine is of scientific interest.
Materials and methods: The search for active compounds was carried out by in silico and in vitro methods. At the first stage, a computer forecast of A1-antagonistic activity was carried out using the Microcosm BioS software. At the second stage, the prediction results were verified in vitro in a model of isolated mouse atria.
Results and discussion: Based on the results of the prediction by the method of maximum similarity to standards, the most active compounds III, VIII, and XVII were selected. After testing the prediction results by the isolated atria method, the compound VIII was characterized by A1-blocking effect in vitro at a concentration of 10 μmol/L.
Conclusion: The most promising compound with A1-blocking effect in vitro was identified; it is a derivative of tetrazolo[1,5-a]pyrimidine under the code of VIII. It is of interest for us for further in-depth study of its pharmacological properties.
Collapse
|
4
|
Discovery of Nitro-azolo[1,5-a]pyrimidines with Anti-Inflammatory and Protective Activity against LPS-Induced Acute Lung Injury. Pharmaceuticals (Basel) 2022; 15:ph15050537. [PMID: 35631365 PMCID: PMC9146423 DOI: 10.3390/ph15050537] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/18/2022] [Revised: 04/19/2022] [Accepted: 04/22/2022] [Indexed: 01/08/2023] Open
Abstract
Acute lung injury remains a challenging clinical condition, necessitating the development of novel, safe and efficient treatments. The prevention of macrophage M1-polarization is a viable venue to tackle excessive inflammation. We performed a phenotypic screening campaign to identify azolopyrimidine compounds that effectively inhibit LPS-induced NO synthesis and interleukin 6 (IL-6) secretion. We identified lead compound 9g that inhibits IL-6 secretion with IC50 of 3.72 µM without apparent cytotoxicity and with minimal suppression of macrophage phagocytosis in contrast to dexamethasone. In a mouse model of LPS-induced acute lung injury, 30 mg/kg i.p. 9g ameliorated anxiety-like behavior, inhibited IL-6 release, and limited neutrophil infiltration and pulmonary edema. A histological study confirmed the protective activity of 9g. Treatment with compound 9g prevented the migration of CD68+ macrophages and the incidence of hemorrhage. Hence, we have identified a promising pharmacological approach for the treatment of acute lung injury that may hold promise for the development of novel drugs against cytokine-mediated complications of bacterial and viral infections.
Collapse
|
5
|
Artem'ev GA, Rusinov VL, Kopchuk DS, Savchuk MI, Santra S, Ulomsky EN, Zyryanov GV, Majee A, Du W, Charushin VN, Chupakhin ОN. Synthetic approaches to 1,2,4-triazolo[5,1- c][1,2,4]triazin-7-ones as basic heterocyclic structures of the antiviral drug Riamilovir ("Triazavirin®") active against SARS-CoV-2 (COVID-19). Org Biomol Chem 2022; 20:1828-1837. [PMID: 35137762 DOI: 10.1039/d1ob02125g] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
Fragments of 1,2,4-triazolo[5,1-c][1,2,4]triazin-7-one are found in many compounds with various types of biological activities, including the antiviral drug Riamilovir (Triazavirin®), which shows activity against SARS-CoV-2 (COVID-19). Therefore, the development of convenient methods for the synthesis of new derivatives of 1,2,4-triazolo[5,1-c][1,2,4]triazin-7-one is always in demand. This review systematizes the information on the most common synthetic methods for constructing the 1,2,4-triazolo[5,1-c][1,2,4]triazin-7-one heterocyclic system.
Collapse
Affiliation(s)
- Grigory A Artem'ev
- I. Ya. Postovskiy Institute of Organic Synthesis, UB of the RAS, 22 S. Kovalevskoy Str., Yekaterinburg, 620219, Russian Federation
- Ural Federal University, 19 Mira str., Yekaterinburg, 620002, Russian Federation.
| | - Vladimir L Rusinov
- I. Ya. Postovskiy Institute of Organic Synthesis, UB of the RAS, 22 S. Kovalevskoy Str., Yekaterinburg, 620219, Russian Federation
- Ural Federal University, 19 Mira str., Yekaterinburg, 620002, Russian Federation.
| | - Dmitry S Kopchuk
- I. Ya. Postovskiy Institute of Organic Synthesis, UB of the RAS, 22 S. Kovalevskoy Str., Yekaterinburg, 620219, Russian Federation
- Ural Federal University, 19 Mira str., Yekaterinburg, 620002, Russian Federation.
| | - Maria I Savchuk
- I. Ya. Postovskiy Institute of Organic Synthesis, UB of the RAS, 22 S. Kovalevskoy Str., Yekaterinburg, 620219, Russian Federation
- Ural Federal University, 19 Mira str., Yekaterinburg, 620002, Russian Federation.
| | - Sougata Santra
- Ural Federal University, 19 Mira str., Yekaterinburg, 620002, Russian Federation.
| | - Eugeny N Ulomsky
- I. Ya. Postovskiy Institute of Organic Synthesis, UB of the RAS, 22 S. Kovalevskoy Str., Yekaterinburg, 620219, Russian Federation
- Ural Federal University, 19 Mira str., Yekaterinburg, 620002, Russian Federation.
| | - Grigory V Zyryanov
- I. Ya. Postovskiy Institute of Organic Synthesis, UB of the RAS, 22 S. Kovalevskoy Str., Yekaterinburg, 620219, Russian Federation
- Ural Federal University, 19 Mira str., Yekaterinburg, 620002, Russian Federation.
| | - Adinath Majee
- Department of Chemistry; Visva-Bharati (A Central University), Santiniketan 731235, India
| | - Weijie Du
- Department of Pharmacology (State-Province Key Laboratories of Biomedicine Pharmaceutics of China, Key Laboratory of Cardiovascular research, Ministry of Education), College of Pharmacy, Harbin Medical University, Harbin, 150081, China
| | - Valery N Charushin
- I. Ya. Postovskiy Institute of Organic Synthesis, UB of the RAS, 22 S. Kovalevskoy Str., Yekaterinburg, 620219, Russian Federation
- Ural Federal University, 19 Mira str., Yekaterinburg, 620002, Russian Federation.
| | - Оleg N Chupakhin
- I. Ya. Postovskiy Institute of Organic Synthesis, UB of the RAS, 22 S. Kovalevskoy Str., Yekaterinburg, 620219, Russian Federation
- Ural Federal University, 19 Mira str., Yekaterinburg, 620002, Russian Federation.
| |
Collapse
|
6
|
Savateev KV, Spasov AA, Rusinov VL. SMALL SYNTHETIC MOLECULES WITH ANTIGLYCATION ACTIVITY. STRUCTURE - ACTIVITY RELATIONSHIP. RUSSIAN CHEMICAL REVIEWS 2022. [DOI: 10.1070/rcr5041] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
|
7
|
Goudarzi A, Ghassemzadeh M, Saeidifar M, Aghapoor K, Mohsenzadeh F, Neumüller B. In vitro cytotoxicity and antibacterial activity of [Pd(AMTTO)(PPh 3) 2]: a novel promising palladium( ii) complex. NEW J CHEM 2022. [DOI: 10.1039/d1nj05545c] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/16/2022]
Abstract
The synthesis and characterization of a novel palladium complex based on a bioactive 3-mercapto-1,2,4-triazine derivative have been investigated. The Pd(ii) complex showed excellent anticancer and antibacterial activity.
Collapse
Affiliation(s)
- Atousa Goudarzi
- Department of Inorganic Chemistry, Chemistry & Chemical Engineering Research Center of Iran, Pajoohesh Blvd., 17th Km of Tehran–Karaj Highway, Tehran 14968-13151, Iran
| | - Mitra Ghassemzadeh
- Department of Inorganic Chemistry, Chemistry & Chemical Engineering Research Center of Iran, Pajoohesh Blvd., 17th Km of Tehran–Karaj Highway, Tehran 14968-13151, Iran
| | - Maryam Saeidifar
- Department of Nanotechnology and Advanced Materials, Materials and Energy Research Center, Karaj, Iran
| | - Kioumars Aghapoor
- Department of Inorganic Chemistry, Chemistry & Chemical Engineering Research Center of Iran, Pajoohesh Blvd., 17th Km of Tehran–Karaj Highway, Tehran 14968-13151, Iran
| | - Farshid Mohsenzadeh
- Department of Inorganic Chemistry, Chemistry & Chemical Engineering Research Center of Iran, Pajoohesh Blvd., 17th Km of Tehran–Karaj Highway, Tehran 14968-13151, Iran
| | - Bernhard Neumüller
- Fachbereich Chemie, Philipps-Universität Marburg, Hans-Meerwein-Strasse, 35032 Marburg, Germany
| |
Collapse
|
8
|
Alizadeh SR, Ebrahimzadeh MA. Pyrazolotriazines: Biological activities, synthetic strategies and recent developments. Eur J Med Chem 2021; 223:113537. [PMID: 34147747 DOI: 10.1016/j.ejmech.2021.113537] [Citation(s) in RCA: 10] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/16/2020] [Revised: 05/03/2021] [Accepted: 05/10/2021] [Indexed: 10/21/2022]
Abstract
Heterocyclic compounds create an important class of molecules that demonstrates various chemical spaces for the definition of effective medicines. Many N-heterocycles display numerous biological activities. Among condensed heterocycles, pyrazolotriazine derivatives have received the attention of researchers owing to the extensive spectrum of biological activities. The reactivity of identified compounds was similar to the free azoles and triazines. The pyrazolotriazine scaffold exhibited antiasthma, antiinflammatory, anticancer, antithrombogenic activity and showed activity for major depression and pathological anxiety. Pyrazolotriazine derivatives also exhibited antibacterial, anticancer, antimetabolites, antidiabetic, antiamoebic, anticonvulsant, antiproliferative activity, human carbonic anhydrase inhibition, cyclin-dependent kinase 2 inhibition, tyrosinase and urease inhibition, MAO-B inhibition, TTK inhibition, thymidine phosphorylase inhibition, tubulin polymerization inhibition, protoporphyrinogen oxidase inhibition, GABAA agonistic activity, hCRF1 receptor antagonistic activity, and CGRP receptor antagonistic activity. This paper structurally categorized various pyrazolotriazines to isomeric classes into six groups that containing pyrazolo [1,5-d] [1,2,4] triazine, pyrazolo [5,1-c] [1,2,4] triazine, pyrazolo [3,4-e] [1,2,4] triazine, pyrazolo [4,3-e] [1,2,4] triazines, pyrazolo [1,5-a] [1,3,5] triazine, and pyrazolo [3,4-d] [1,2,3] triazine and expressed biological activity, the synthetic procedures for each class of pyrazolotriazines, structure-activity relationship and their mechanism of action. Generally, this review summarily indicated the past and present studies about the discovery of new lead compounds with good biological activity.
Collapse
Affiliation(s)
- Seyedeh Roya Alizadeh
- Department of Medicinal Chemistry, School of Pharmacy and Pharmaceutical Sciences Research Center, Hemoglobinopathy Institute, Mazandaran University of Medical Sciences, Sari, Iran
| | - Mohammad Ali Ebrahimzadeh
- Department of Medicinal Chemistry, School of Pharmacy and Pharmaceutical Sciences Research Center, Hemoglobinopathy Institute, Mazandaran University of Medical Sciences, Sari, Iran.
| |
Collapse
|
9
|
Neural network modeling search for multitarget RAGE inhibitors with different target activity spectra. Russ Chem Bull 2021. [DOI: 10.1007/s11172-021-3125-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
10
|
Litvinov RA, Drokin RA, Shamshina DD, Kalenova MY, Usmianova LE, Muraveva EA, Vasiliev PM, Voinkov EK, Ulomskiy EN, Spasov AA, Rusinov VL. Prediction of Antiglycation Activity by Calculating the Energies of Frontier Molecular Orbitals for New 4-Hydroxy-1,4-Dihydroazolo[5,1-c]-1,2,4-Triazines Used as an Example. RUSSIAN JOURNAL OF BIOORGANIC CHEMISTRY 2020. [DOI: 10.1134/s1068162020060175] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
|
11
|
Voinkov EK, Drokin RA, Ulomsky EN, Chupakhin ON, Charushin VN, Rusinov VL. Methods of Synthesis for the Azolo[1,2,4]Triazines. Chem Heterocycl Compd (N Y) 2020. [DOI: 10.1007/s10593-020-02808-z] [Citation(s) in RCA: 9] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
12
|
Sadchikova EV, Alexeeva DL, Nenajdenko VG. Trifluoroacetyl substituted pyrazolotriazines: synthesis and pathways of formation. MENDELEEV COMMUNICATIONS 2020. [DOI: 10.1016/j.mencom.2020.03.016] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
13
|
Pogaku V, Gangarapu K, Basavoju S, Tatapudi KK, Katragadda SB. Design, synthesis, molecular modelling, ADME prediction and anti-hyperglycemic evaluation of new pyrazole-triazolopyrimidine hybrids as potent α-glucosidase inhibitors. Bioorg Chem 2019; 93:103307. [DOI: 10.1016/j.bioorg.2019.103307] [Citation(s) in RCA: 23] [Impact Index Per Article: 4.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/25/2019] [Revised: 09/13/2019] [Accepted: 09/19/2019] [Indexed: 12/14/2022]
|
14
|
Lyapustin DN, Ulomsky EN, Zanakhov TO, Rusinov VL. Three-Component Coupling of Aromatic Aldehydes, 1-Morpholino-2-nitroalkenes, and 3-Aminoazoles via Boron Trifluoride Etherate Catalysis: Reaction Pathway and Features of the Formation of Intermediates. J Org Chem 2019; 84:15267-15275. [DOI: 10.1021/acs.joc.9b02286] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/10/2023]
Affiliation(s)
- Daniil N. Lyapustin
- Department of Organic and Biomolecular Chemistry, Ural Federal University, Mira St. 19, 620002 Ekaterinburg, Russia
| | - Evgeny N. Ulomsky
- Department of Organic and Biomolecular Chemistry, Ural Federal University, Mira St. 19, 620002 Ekaterinburg, Russia
| | - Timur O. Zanakhov
- Institute of Chemistry, Saint-Petersburg State University, Universitetskii pr. 26, 198504 St. Petersburg, Russia
| | - Vladimir L. Rusinov
- Department of Organic and Biomolecular Chemistry, Ural Federal University, Mira St. 19, 620002 Ekaterinburg, Russia
| |
Collapse
|
15
|
Savateev K, Fedotov V, Butorin I, Eltsov O, Slepukhin P, Ulomsky E, Rusinov V, Litvinov R, Babkov D, Khokhlacheva E, Radaev P, Vassiliev P, Spasov A. Nitrothiadiazolo[3,2-a]pyrimidines as promising antiglycating agents. Eur J Med Chem 2019; 185:111808. [PMID: 31683103 DOI: 10.1016/j.ejmech.2019.111808] [Citation(s) in RCA: 15] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/10/2019] [Revised: 10/19/2019] [Accepted: 10/21/2019] [Indexed: 12/30/2022]
Abstract
Managing the advanced glycation end-products (AGEs) concentration is a reliable approach to achieve control over the pathogenesis of diabetic vascular complications. Inhibition of dipeptidyl peptidase-4 (DPP-4) is also an attractive way to tackle type 2 diabetes mellitus (T2DM). We showed previously that azoloazine heterocycles have the potential to prevent the formation of AGEs and in this work, we conducted docking studies with DPP-4 of 5-alkylamino-6-nitro-1,3,4-thiadiazolo[3,2-a]pyrimidines. Consequently, we have developed a synthetic approach to these structures by chlorodeoxygenation and amination reactions. Antidiabetic properties of obtained compounds were studied by evaluating DPP-4 (ex vivo/in vitro) and AGEs formation inhibition (in vitro). It was shown that the nitrothiadiazolopyrimidines exhibit a higher antiglycation activity than reference compound aminoguanidine, but only moderate inhibition of DPP-4. The most active DPP-4 inhibitor 1l had IC50 of 55.87 μM and showed the ability to inhibit serum DPP-4 activity in rats after 10 mg/kg oral administration but with the less and shorter effect than vildagliptin. At the same time, 1l was the most active antiglycating compound in the series (IC50 134.4 μM). Copper chelation properties of synthesized compounds were also investigated since the formation of AGEs is catalyzed by the transition metal cations. A noticeable correlation between antiglycation activity and metal chelation was revealed. Both activities (antiglycation and copper chelation) correlated with quantum-chemical properties (calculated with ab initio) of the tested compounds. These findings will allow us to predict both activities in the future, without the need to model multiple steps of glycation reaction.
Collapse
Affiliation(s)
- Konstantin Savateev
- Department of Organic and Biomolecular Chemistry, Ural Federal University Named After the First President of Russia B.N. Eltsin, Mira st. 19, Yekaterinburg, 620002, Russian Federation.
| | - Victor Fedotov
- Department of Organic and Biomolecular Chemistry, Ural Federal University Named After the First President of Russia B.N. Eltsin, Mira st. 19, Yekaterinburg, 620002, Russian Federation
| | - Ilya Butorin
- Department of Organic and Biomolecular Chemistry, Ural Federal University Named After the First President of Russia B.N. Eltsin, Mira st. 19, Yekaterinburg, 620002, Russian Federation
| | - Oleg Eltsov
- Department of Organic and Biomolecular Chemistry, Ural Federal University Named After the First President of Russia B.N. Eltsin, Mira st. 19, Yekaterinburg, 620002, Russian Federation
| | - Pavel Slepukhin
- Institute of Organic Synthesis of the Ural Branch of the Russian Academy of Science, Sofii Kovalevskoy st. 22, Yekaterinburg, 620137, Russian Federation
| | - Evgeny Ulomsky
- Department of Organic and Biomolecular Chemistry, Ural Federal University Named After the First President of Russia B.N. Eltsin, Mira st. 19, Yekaterinburg, 620002, Russian Federation
| | - Vladimir Rusinov
- Department of Organic and Biomolecular Chemistry, Ural Federal University Named After the First President of Russia B.N. Eltsin, Mira st. 19, Yekaterinburg, 620002, Russian Federation
| | - Roman Litvinov
- Volgograd State Medical University, Pavshikh Bortsov Sq., Volgograd, 400131, Russian Federation
| | - Denis Babkov
- Volgograd State Medical University, Pavshikh Bortsov Sq., Volgograd, 400131, Russian Federation
| | - Elisaveta Khokhlacheva
- Volgograd State Medical University, Pavshikh Bortsov Sq., Volgograd, 400131, Russian Federation
| | - Pyotr Radaev
- Volgograd State Medical University, Pavshikh Bortsov Sq., Volgograd, 400131, Russian Federation
| | - Pavel Vassiliev
- Volgograd State Medical University, Pavshikh Bortsov Sq., Volgograd, 400131, Russian Federation
| | - Alexandr Spasov
- Volgograd State Medical University, Pavshikh Bortsov Sq., Volgograd, 400131, Russian Federation
| |
Collapse
|
16
|
Stable Isotope-Labeled Azoloazines. Synthesis of a 13С and 15N Isotope-Enriched Derivative of Pyrazolo[5,1-c][1,2,4]Triazine –Potential Antidiabetic Agent. Chem Heterocycl Compd (N Y) 2019. [DOI: 10.1007/s10593-019-02549-8] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
17
|
|
18
|
Konovalov AI, Antipin IS, Burilov VA, Madzhidov TI, Kurbangalieva AR, Nemtarev AV, Solovieva SE, Stoikov II, Mamedov VA, Zakharova LY, Gavrilova EL, Sinyashin OG, Balova IA, Vasilyev AV, Zenkevich IG, Krasavin MY, Kuznetsov MA, Molchanov AP, Novikov MS, Nikolaev VA, Rodina LL, Khlebnikov AF, Beletskaya IP, Vatsadze SZ, Gromov SP, Zyk NV, Lebedev AT, Lemenovskii DA, Petrosyan VS, Nenaidenko VG, Negrebetskii VV, Baukov YI, Shmigol’ TA, Korlyukov AA, Tikhomirov AS, Shchekotikhin AE, Traven’ VF, Voskresenskii LG, Zubkov FI, Golubchikov OA, Semeikin AS, Berezin DB, Stuzhin PA, Filimonov VD, Krasnokutskaya EA, Fedorov AY, Nyuchev AV, Orlov VY, Begunov RS, Rusakov AI, Kolobov AV, Kofanov ER, Fedotova OV, Egorova AY, Charushin VN, Chupakhin ON, Klimochkin YN, Osyanin VA, Reznikov AN, Fisyuk AS, Sagitullina GP, Aksenov AV, Aksenov NA, Grachev MK, Maslennikova VI, Koroteev MP, Brel’ AK, Lisina SV, Medvedeva SM, Shikhaliev KS, Suboch GA, Tovbis MS, Mironovich LM, Ivanov SM, Kurbatov SV, Kletskii ME, Burov ON, Kobrakov KI, Kuznetsov DN. Modern Trends of Organic Chemistry in Russian Universities. RUSSIAN JOURNAL OF ORGANIC CHEMISTRY 2018. [DOI: 10.1134/s107042801802001x] [Citation(s) in RCA: 62] [Impact Index Per Article: 10.3] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
|
19
|
Antipin IS, Kazymova MA, Kuznetsov MA, Vasilyev AV, Ishchenko MA, Kiryushkin AA, Kuznetsova LM, Makarenko SV, Ostrovskii VA, Petrov ML, Solod OV, Trishin YG, Yakovlev IP, Nenaidenko VG, Beloglazkina EK, Beletskaya IP, Ustynyuk YA, Solov’ev PA, Ivanov IV, Malina EV, Sivova NV, Negrebetskii VV, Baukov YI, Pozharskaya NA, Traven’ VF, Shchekotikhin AE, Varlamov AV, Borisova TN, Lesina YA, Krasnokutskaya EA, Rogozhnikov SI, Shurov SN, Kustova TP, Klyuev MV, Khelevina OG, Stuzhin PA, Fedorov AY, Gushchin AV, Dodonov VA, Kolobov AV, Plakhtinskii VV, Orlov VY, Kriven’ko AP, Fedotova OV, Pchelintseva NV, Charushin VN, Chupakhin ON, Klimochkin YN, Klimochkina AY, Kuryatnikov VN, Malinovskaya YA, Levina AS, Zhuravlev OE, Voronchikhina LI, Fisyuk AS, Aksenov AV, Aksenov NA, Aksenova IV. Organic chemistry. History and mutual relations of universities of Russia. RUSSIAN JOURNAL OF ORGANIC CHEMISTRY 2018. [DOI: 10.1134/s1070428017090019] [Citation(s) in RCA: 45] [Impact Index Per Article: 7.5] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
|
20
|
Spasov AA, Babkov DA, Sysoeva VA, Litvinov RA, Shamshina DD, Ulomsky EN, Savateev KV, Fedotov VV, Slepukhin PA, Chupakhin ON, Charushin VN, Rusinov VL. 6-Nitroazolo[1,5-a
]pyrimidin-7(4H
)-ones as Antidiabetic Agents. Arch Pharm (Weinheim) 2017; 350. [DOI: 10.1002/ardp.201700226] [Citation(s) in RCA: 21] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/14/2017] [Revised: 10/09/2017] [Accepted: 10/10/2017] [Indexed: 11/07/2022]
Affiliation(s)
- Alexander A. Spasov
- Volgograd State Medical University Research Institute of Pharmacology; Pavshikh Volgograd Russia
| | - Denis A. Babkov
- Volgograd State Medical University Research Institute of Pharmacology; Pavshikh Volgograd Russia
| | - Valentina A. Sysoeva
- Volgograd State Medical University Research Institute of Pharmacology; Pavshikh Volgograd Russia
| | - Roman A. Litvinov
- Volgograd State Medical University Research Institute of Pharmacology; Pavshikh Volgograd Russia
| | - Darya D. Shamshina
- Volgograd State Medical University Research Institute of Pharmacology; Pavshikh Volgograd Russia
| | - Evgeny N. Ulomsky
- Ural Federal University named after the First President of Russia B.N. Eltsin; Yekaterinburg Russia
| | - Konstantin V. Savateev
- Ural Federal University named after the First President of Russia B.N. Eltsin; Yekaterinburg Russia
| | - Viktor V. Fedotov
- Ural Federal University named after the First President of Russia B.N. Eltsin; Yekaterinburg Russia
| | - Pavel A. Slepukhin
- Institute of Organic Synthesis of the Ural Branch of the Russian Academy of Science; Yekaterinburg Russia
| | - Oleg N. Chupakhin
- Ural Federal University named after the First President of Russia B.N. Eltsin; Yekaterinburg Russia
- Institute of Organic Synthesis of the Ural Branch of the Russian Academy of Science; Yekaterinburg Russia
| | - Valery N. Charushin
- Ural Federal University named after the First President of Russia B.N. Eltsin; Yekaterinburg Russia
- Institute of Organic Synthesis of the Ural Branch of the Russian Academy of Science; Yekaterinburg Russia
| | - Vladimir L. Rusinov
- Ural Federal University named after the First President of Russia B.N. Eltsin; Yekaterinburg Russia
- Institute of Organic Synthesis of the Ural Branch of the Russian Academy of Science; Yekaterinburg Russia
| |
Collapse
|